15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English HBcrAg对无肝病或肝炎的慢性感染中1582 HBeAg阴性个体进 ...
查看: 334|回复: 1
go

HBcrAg对无肝病或肝炎的慢性感染中1582 HBeAg阴性个体进行分类 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2021-1-21 16:45 |只看该作者 |倒序浏览 |打印
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis
Maurizia R Brunetto  1 , Ivana Carey  2 , Benjamin Maasoumy  3 , Cristina Marcos-Fosch  4 , André Boonstra  5 , Gian Paolo Caviglia  6 , Alessandro Loglio  7 , Daniela Cavallone  1 , Caroline Scholtes  8 , Gabriele Ricco  1 , Antonina Smedile  6 , Mar Riveiro-Barciela  4 , Florian van Bömmel  9 , Annemiek van der Eijk  5 , Fabien Zoulim  8 , Thomas Berg  9 , Markus Cornberg  3 , Pietro Lampertico  7 , Kosh Agarwal  2 , Maria Buti  4
Affiliations
Affiliations

    1
    Pisa, Italy.
    2
    London, UK.
    3
    Hannover, Germany.
    4
    Barcelona, Spain.
    5
    Rotterdam, the Netherlands.
    6
    Turin, Italy.
    7
    Milan, Italy.
    8
    Lyon, France.
    9
    Leipzig, Germany.

    PMID: 33465257 DOI: 10.1111/apt.16258

Abstract

Background: An accurate, single-point differential diagnosis between HBeAg-negative infection (ENI) and chronic hepatitis B (CHB) is an unmet need.

Aims: To assess the diagnostic value of the new hepatitis B core-related antigen (HBcrAg) assay.

Methods: A retrospective anonymised data analysis was performed in a multicentre European (nine centres and six countries) cohort of 1582 consecutive HBsAg-positive/HBeAg-negative subjects classified according to EASL guidelines as: 550-CHB, 710-ENI and 322-GZ (grey-zone, HBV-DNA <20 000 IU/mL).

Results: Mean age was 44 (±13.2 y), 59% were men; HBV genotypes were 15% A, 2% B, 2% C, 45% D, 9% E, 1% F and 26% unknown. Median HBV-DNA serum levels were 2.2 (1.5-2.7), 3.5 (3.2-3.8) and 5.6 (4.8-6.6) logIU/mL in ENI, GZ and CHB, P < 0.0001. HBsAg serum levels (HBsAgsl) were comparable in CHB and GZ, but lower in ENI (2.9 [2.1-3.6] logIU/mL), P < 0.0001. HBcrAg serum levels (HBcrAgsl) were <3 logU/mL in 90.7% (644/710) ENI, 75.2% (242/322) GZ and 4.7% (26/550) CHB (P < 0.0001). Median HBcrAgsl were 4.8 (3.9-5.7), 2.5 (2.0-2.9) and 2.0 (2.0-2.5) logU/mL in CHB, GZ and ENI, (P < 0.0001). ROC-AUCs for HBcrAg and HBsAg were 0.968 (95% CI, 0.958-0.977) and 0.732 (95% CI, 0.704-0.760) respectively. The optimal HBcrAgsl cut-off to distinguish CHB from ENI was 3.14 logU/mL (95% CI, 3.02-3.25, 91% SE, 93% SP and 92.4% DA). HBcrAgsl were associated with HBV genotypes (P < 0.001, one-way ANOVA) but using genotype-specific cut-offs, HBcrAg DA remained unchanged with overlapping 95% CI.

Conclusion: The HBcrAg assay showed high diagnostic performance in the accurate single-point identification of patients with HBeAg-negative CHB, independently of HBV genotype. This should prompt future prospective studies to confirm its diagnostic role in clinical practice.

© 2021 John Wiley & Sons Ltd.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2021-1-21 16:45 |只看该作者
HBcrAg对无肝病或肝炎的慢性感染中1582 HBeAg阴性个体进行分类的增值
Maurizia R Brunetto 1,Ivana Carey 2,Benjamin Maasoumy 3,Cristina Marcos-Fosch 4,AndréBoonstra 5,Gian Paolo Caviglia 6,Alessandro Loglio 7,Daniela Cavallone 1,Caroline Scholtes 8,Gabriele Ricco 1,Antonina Smedile 6,Mar Rive -Barciela 4,Florian vanBömmel9,Annemiek van der Eijk 5,Fabien Zoulim 8,Thomas Berg 9,Markus Cornberg 3,Pietro Lampertico 7,Kosh Agarwal 2,Maria Buti 4
隶属关系
隶属关系

    1个
    意大利比萨。
    2
    英国伦敦。
    3
    德国汉诺威。
    4
    西班牙巴塞罗那。
    5
    荷兰鹿特丹。
    6
    意大利都灵。
    7
    意大利米兰。
    8
    法国里昂。
    9
    德国莱比锡。

    PMID:33465257 DOI:10.1111 / apt.16258

抽象

背景:HBeAg阴性感染(ENI)与慢性乙型肝炎(CHB)之间的准确,单点鉴别诊断是未满足的需求。

目的:评估新的乙型肝炎核心相关抗原(HBcrAg)检测方法的诊断价值。

方法:在多中心欧洲(九个中心和六个国家)队列中,对1582名连续的HBsAg阳性/ HBeAg阴性受试者进行了回顾性匿名数据分析,根据EASL指南将其分为:550-CHB,710-ENI和322-GZ (灰色区,HBV-DNA <20000 IU / mL)。

结果:平均年龄为44岁(±13.2岁),男性为59%; HBV基因型分别为15%A,2%B,2%C,45%D,9%E,1%F和26%未知。 ENI,GZ和CHB中的HBV-DNA血清中位水平分别为2.2(1.5-2.7),3.5(3.2-3.8)和5.6(4.8-6.6)logIU / mL,P <0.0001。 HBsAg血清水平(HBsAgsl)在CHB和GZ中相当,但在ENI中较低(2.9 [2.1-3.6] logIU / mL),P <0.0001。 90.7%(644/710)ENI,75.2%(242/322)GZ和4.7%(26/550)CHB中的HBcrAg血清水平(HBcrAgsl)<3 logU / mL(P <0.0001)。在CHB,GZ和ENI中,HBcrAgs1的中位数分别为4.8(3.9-5.7),2.5(2.0-2.9)和2.0(2.0-2.5)logU / mL(P <0.0001)。 HBcrAg和HBsAg的ROC-AUC分别为0.968(95%CI,0.958-0.977)和0.732(95%CI,0.704-0.760)。区分CHB与ENI的最佳HBcrAgsl临界值是3.14 logU / mL(95%CI,3.02-3.25、91%SE,93%SP和92.4%DA)。 HBcrAgs1与HBV基因型相关(P <0.001,单向方差分析),但使用基因型特异的临界值,HBcrAg DA保持不变,重叠95%CI。

结论:HBcrAg测定法可独立于HBV基因型对HBeAg阴性CHB患者进行准确的单点鉴定,具有较高的诊断性能。这应该促使未来的前瞻性研究证实其在临床实践中的诊断作用。

©2021 John Wiley&Sons Ltd.
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-20 21:14 , Processed in 0.014270 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.